ACE-2-derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2

enthalten in: chemRxiv.org | 2021

von Panda, S. | Gupta, P. | Biswal, S. | +2

In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells

enthalten in: chemRxiv.org | 2021

von Nguyen, B.

In-Silico FDA-Approved Drug Repurposing to Find the Possible Treatment of Coronavirus Disease-19 (COVID-19)

enthalten in: chemRxiv.org | 2021

von Sharp, K. | Dange, D.

Nature to Nurture- Identifying Phytochemicals from Indian Medicinal Plants as Prophylactic Medicine by Rational Screening to Be Potent Against Multiple Drug Targets of SARS-CoV-2

enthalten in: chemRxiv.org | 2021

von Parida, P. | Paul, D. | Chakravorty, D.

Direct ACE2- Spike RBD Binding Disruption with Small Molecules: A Strategy for COVID-19 Treatment

enthalten in: chemRxiv.org | 2021

von Smieszek, S. | Przychodzen, B. | Polymeropoulos, V. | +2

How Does the Novel Coronavirus Interact with the Human ACE2 Enzyme? A Thermodynamic Answer

enthalten in: chemRxiv.org | 2021

von de Andrade, J. | Gonçalves, P. | Netz, P.

Intermolecular Interaction Among Remdesivir, RNA and RNA-Dependent RNA Polymerase of SARS-CoV-2 Analyzed by Fragment Molecular Orbital Calculation

enthalten in: chemRxiv.org | 2021

von Kato, K. | Honma, T. | Fukuzawa, K.

Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19

enthalten in: chemRxiv.org | 2021

von Rehman, M. | AlAjmi, M. | Hussain, A.

Establishment and Validation of a Drug-Target Microarray for SARS-CoV-2

enthalten in: chemRxiv.org | 2021

von Chen, P. | Zeng, Z. | Du, H.

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19

enthalten in: chemRxiv.org | 2021

von Kumar, S. | Kumari, P. | Agnihotri, G. | +4